# PB-001 — Go / No-Go Minutes (Stage 1)

**Programme:** PB-001 — Stage 1 Go/No-Go Review  
**Meeting type:** Product Board Stage 1 enrollment evidence review  
**Date:** 2026-07-26  
**Status:** Minutes of evidence review — recommendation recorded; human role countersignatures optional for archive  
**Decision subject:** First external participant invitation  
**Engineering / Runtime A:** Untouched  

---

## 1. Attendance (roles)

| Role | Present for evidence review |
|---|---|
| Chair / Product Governance Lead | Yes (programme synthesis) |
| Evidence Lead | Yes (programme synthesis) |
| Security Representative (privacy posture) | Evidence cited; signature on Privacy Review remains **OPEN** |
| Educational Representative | Effectiveness posture restated (**NO-GO**) |
| Engineering / Ops Representative | Ops packages cited; §E evidence remains **OPEN** |

Named individual countersignatures for Privacy Review and go-live §E are **out of band** and remain blank in source packages — this meeting does not invent them.

---

## 2. Question put to the Board

> Should Kwalitec invite its first external participant?

---

## 3. Evidence package presented

1. `VERSION_1_READINESS.md` — Stage 1 packages complete; Critical signatures/evidence OPEN; enrollment HOLD  
2. P-003.7 Product Board Charter — evidence before opinion; no unsupported claims  
3. P-003.8 Exit Criteria / Current Release Position — Version 1 **NO GO** (separable from Stage 1)  
4. P-003.3 Risk Register — PR-003 Privacy Review unsigned; PR-006/007 external cohort unavailable  
5. P-003.5 Evidence Hierarchy + Claim Standard — no fabricated evidence; Stage 1 GO requires operational evidence  
6. EP-008.2A Operational Readiness — Critical OR-01 / OR-02 open at assessment  
7. EP-008.2B Privacy Sign-off, Pilot Readiness, Go-Live Checklist, Rollback Playbook, Operational Sign-off Summary — documentation COMPLETE; demonstrable Critical closure OPEN  

---

## 4. Verification findings (read into the record)

| Item | Finding |
|---|---|
| Privacy Review signatures | **Absent** — Product and Security/ops rows blank |
| Named operational owners | Roles designated; activation-log **names unconfirmed** |
| Export exercise | **Not recorded** — §E1 blank |
| Deletion exercise | **Not recorded** — §E2 blank |
| Kill-switch rehearsal (Stage 1 Pilot target) | **Not recorded** — §E3 / playbook rehearsal blank |
| Dry-run | **Not completed** as evidenced |
| Behavioural instrumentation | Documented; Pilot analytics enable **HOLD** |
| Rollback procedure | Documented; rehearsal **not evidenced** |
| Participant onboarding | Documented; no external live run (N=0) |
| Consent flow | Wording ready; live capture **not started** |

**Critical items lacking evidence:** OR-01 (signatures); OR-02 (dry-run / kill-switch / go-live evidence).

---

## 5. Discussion notes (evidence-bound)

- Conflating “package complete” with “blocker closed” would authorise invites under unsigned privacy risk — forbidden by EP-008.2B and Claim Standard honesty.  
- Stage 0 may continue; this HOLD does not revoke DR-040 Stage 0 conditions.  
- Version 1 production-ready remains **NO GO** (KSI 64; G1 FAIL) regardless of Stage 1 outcome; this vote does not reopen DR-041.  
- Educational effectiveness remains **NO-GO / PENDING EVIDENCE** until Stage 1 ops evidence exists (G1.9).  

No member asserted that blank signature or blank §E rows constitute evidence.

---

## 6. Decision rule applied

| Rule | Application |
|---|---|
| Every Critical operational item evidenced → Stage 1 **GO** | Not met |
| Any Critical item lacks evidence → Stage 1 **HOLD** | **Met** |

---

## 7. Decision

| Field | Value |
|---|---|
| **Outcome** | **Stage 1 HOLD** |
| **Invite first external participant?** | **No** |
| **Effective immediately** | Yes |
| **Supersedes** | Does not supersede EP-008.2B HOLD — **reaffirms** it after Board evidence review |
| **Version 1 recommendation** | Unchanged **NO GO** (out of scope) |

---

## 8. Actions recorded

See [`OPEN_ACTION_REGISTER.md`](OPEN_ACTION_REGISTER.md). Summary:

1. Obtain Privacy Review Product + Security/ops signatures.  
2. Execute and attach export/delete dry-run + kill-switch rehearsal (§E).  
3. Confirm named owners on activation log.  
4. Record Rollout Stage 1 Go only when G-S1-* clear; then invite.  

---

## 9. Claim language after this meeting

**May say:** “Product Board Stage 1 evidence review (PB-001) retains HOLD; Critical operational evidence is incomplete.”  

**Must not say:** “Stage 1 GO”; “Privacy signed”; “Dry-run done”; “External pilot started”; “Version 1 production-ready.”

---

## 10. Adjournment

Review closed 2026-07-26. Reconvene only when Critical evidence paths are filed (not when further documentation alone is produced).

---

**End of GO_NO_GO_MINUTES**
